Lifeward achieves CE mark approval for the ReWalk 7 Personal Exoskeleton

Lifeward (LFWD) “announced that the company has received CE mark approval for the ReWalk 7 Personal Exoskeleton, clearing it for commercial sale in Europe. The seventh generation of the ReWalk, which includes innovative new and enhanced features such as cloud connectivity, push-button control, customizable walking speeds, and seamless activation of stairs and curbs, will now be available to European customers, who currently represent approximately 40% of Lifeward’s exoskeleton sales. The majority of these sales are generated through Lifeward GmbH, where the process of reimbursement for personal exoskeletons has been broadly established for individuals in Germany. Previous generations of the ReWalk Exoskeleton have been available in Europe since the company received its initial CE mark in 2010. The European market is served through the Company’s Lifeward GmbH salesforce in Germany, which represents the second largest market worldwide for ReWalk personal exoskeletons. Lifeward has established supply contracts with several major insurance carriers in Germany, including BARMER, to facilitate the reimbursement and supply of exoskeletons for approximately 45% of people with statutory health insurance coverage in Germany.”